Cannabis Groups Mobilize for Federal Legalization After Trump Rescheduling
Advocacy organizations launch congressional push for comprehensive cannabis reform, viewing recent rescheduling developments as opening for broader legislative action.
Cannabis advocacy organizations are intensifying their congressional lobbying efforts following recent federal rescheduling developments, viewing the regulatory shift as a strategic opening for comprehensive legalization legislation. The coordinated push represents a calculated attempt to capitalize on evolving federal cannabis policy while maintaining momentum for broader reform measures that could reshape the $30 billion U.S. cannabis market.
The advocacy campaign targets key congressional committees with jurisdiction over drug policy and financial services, areas critical to cannabis banking and interstate commerce regulations. Organizations are emphasizing economic arguments, pointing to state-legal cannabis markets that generated over $15 billion in tax revenue since 2014. The timing coincides with growing bipartisan recognition that current federal-state cannabis policy conflicts create banking complications and tax inefficiencies for legitimate operators.
Multi-state operators like Curaleaf (CURA), Green Thumb Industries (GTII), and Trulieve (TCNNF) would benefit significantly from federal legalization through reduced tax burdens and expanded banking access. Current 280E tax restrictions force cannabis companies to pay effective tax rates exceeding 40%, while banking limitations create operational challenges and limit institutional investment opportunities. Full legalization could unlock estimated market expansion of 200-300% within five years.
The advocacy strategy focuses on incremental reforms rather than comprehensive legalization, recognizing political realities in a divided Congress. Priority measures include the SAFE Banking Act, which would provide financial services access, and federal expungement programs for non-violent cannabis offenses. This pragmatic approach mirrors successful state-level campaigns that achieved legalization through graduated policy changes rather than sweeping legislative overhauls.
Industry analysts view the coordinated advocacy effort as potentially market-moving, particularly if banking reform advances independently of broader legalization measures. Cannabis stocks have historically shown significant volatility around federal policy developments, with the sector gaining over 100% during periods of perceived regulatory progress. The current advocacy push could generate similar investor interest, especially among institutional investors currently restricted by federal compliance concerns.